John A Orwin
CIK 1477384 · PRESIDENT & CEO · last filed 2026-05-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.65M
Companies
9
Total Filings
90
Lifetime Open-Market Net
-$8.30M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TVTX | Director | 39,375 | $52.04 | $2.05M | $0 | 6 | 2026-05-21 |
| TRAX | Director | 10,665 | — | — | $0 | 2 | 2026-05-14 |
| ANAB | Director | 10,665 | $56.07 | $598.0K | $0 | 9 | 2026-04-22 |
| CARGO Therapeutics, Inc. (CRGX) Delisted | Director | — | $4.47 | — | $0 | 4 | 2025-08-19 |
| Seagen Inc. (SGEN) Delisted | Director | 0 | $228.74 | $0 | $56.7K | 12 | 2023-12-15 |
| Atreca, Inc. (BCEL) Delisted | President & CEO | 100,492 | $0.15 | $15.1K | $39.6K | 8 | 2023-02-13 |
| Travere Therapeutics, Inc. (RTRX) Delisted | Director | 11,875 | — | — | $0 | 4 | 2020-05-19 |
| Relypsa Inc (RLYP) Delisted | President & CEO | 0 | — | — | -$3.61M | 12 | 2016-09-02 |
| AFFYMAX INC (AFFY) Delisted | CEO | 108,000 | — | — | -$4.78M | 18 | 2013-02-05 |
Recent Filings · Page 2 of 9
90 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-01-07 | ANAB | Grant (A) | — | $0 | EDGAR |
| 2024-09-17 | ANAB | Exer (M) | +1,300 | $0 | EDGAR |
| 2024-06-18 | ANAB | Exer (M) | +2,035 | $0 | EDGAR |
| 2024-06-06 | CARGO Therapeutics, Inc. (CRGX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-10 | TVTX | Grant (A) | +6,500 | $0 | EDGAR |
| 2024-04-17 | — | Buy (P) | +1 | $0 | |
| 2024-04-03 | — | Sell (S) | −22,951 | -$8.6K | |
| 2024-01-05 | ANAB | Grant (A) | — | $0 | EDGAR |
| 2023-12-15 | Seagen Inc. (SGEN) Delisted | Disp (D) | −29,003 | -$6.64M | EDGAR |
| 2023-11-13 | CARGO Therapeutics, Inc. (CRGX) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.